Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beneficient (BENF) Common Equity (2020 - 2025)

Beneficient's Common Equity history spans 6 years, with the latest figure at -$128.6 million for Q4 2025.

  • On a quarterly basis, Common Equity fell 1001.59% to -$128.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$128.6 million, a 1001.59% decrease, with the full-year FY2025 number at -$34.9 million, up 81.82% from a year prior.
  • Common Equity hit -$128.6 million in Q4 2025 for Beneficient, up from -$142.8 million in the prior quarter.
  • Over the last five years, Common Equity for BENF hit a ceiling of $1.9 billion in Q1 2022 and a floor of -$192.1 million in Q1 2024.
  • Historically, Common Equity has averaged $636.1 million across 5 years, with a median of $14.3 million in 2024.
  • Biggest five-year swings in Common Equity: surged 258.92% in 2024 and later plummeted 1001.59% in 2025.
  • Tracing BENF's Common Equity over 5 years: stood at $1.1 billion in 2021, then skyrocketed by 65.19% to $1.8 billion in 2022, then tumbled by 99.78% to $4.0 million in 2023, then surged by 258.92% to $14.3 million in 2024, then plummeted by 1001.59% to -$128.6 million in 2025.
  • Business Quant data shows Common Equity for BENF at -$128.6 million in Q4 2025, -$142.8 million in Q3 2025, and -$120.4 million in Q2 2025.